China’s Health Care Reform Brings New Opportunities
This article was originally published in PharmAsia News
Executive Summary
China's new health care reform will bring changes and opportunities to the medical business, according to Business China magazine, mainly in the following aspects: transformation of medicine consumption patterns, expanding the third-tier end-user market; adoption of separate management for drug retail and medical treatment, bringing profit to pharmaceutical channels; improvement of the relationship between drug manufacturers, pharmaceutical companies and end-user buyers; and reduction of demand-supply costs by flattening the distribution channels. The new reform will encourage transparency in the drug purchase system and channels, helping to fight against commercial corruption and decrease pharmaceutical corporations' costs. (Click here for more - Chinese Language)
|
China's new health care reform will bring changes and opportunities to the medical business, according to Business China magazine, mainly in the following aspects: transformation of medicine consumption patterns, expanding the third-tier end-user market; adoption of separate management for drug retail and medical treatment, bringing profit to pharmaceutical channels; improvement of the relationship between drug manufacturers, pharmaceutical companies and end-user buyers; and reduction of demand-supply costs by flattening the distribution channels. The new reform will encourage transparency in the drug purchase system and channels, helping to fight against commercial corruption and decrease pharmaceutical corporations' costs. (Click here for more - Chinese Language) "China's Health Care Reform Brings Opportunities For Medical Industry" - Business China (Beijing) (3/5/08) (Monthly magazine) |